Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

A photoswitchable GABA receptor channel blocker.

Maleeva G, Wutz D, Rustler K, Nin-Hill A, Alfonso-Prieto M, Petukhova E, Bautista-Barrufet A, Gomila-Juaneda A, Scholze P, Peiretti F, Rovira C, König B, Gorostiza P, Bregestovski P.

Br J Pharmacol. 2019 Apr 13. doi: 10.1111/bph.14689. [Epub ahead of print]

PMID:
30981211
2.

Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation.

Laghezza A, Piemontese L, Cerchia C, Montanari R, Capelli D, Giudici M, Crestani M, Tortorella P, Peiretti F, Pochetti G, Lavecchia A, Loiodice F.

J Med Chem. 2018 Sep 27;61(18):8282-8298. doi: 10.1021/acs.jmedchem.8b00835. Epub 2018 Sep 18.

PMID:
30199253
3.

The beta secretase BACE1 regulates the expression of insulin receptor in the liver.

Meakin PJ, Mezzapesa A, Benabou E, Haas ME, Bonardo B, Grino M, Brunel JM, Desbois-Mouthon C, Biddinger SB, Govers R, Ashford MLJ, Peiretti F.

Nat Commun. 2018 Apr 3;9(1):1306. doi: 10.1038/s41467-018-03755-2.

4.

Claramines: A New Class Of Broad-Spectrum Antimicrobial Agents With Bimodal Activity.

Blanchet M, Borselli D, Rodallec A, Peiretti F, Vidal N, Bolla JM, Digiorgio C, Morrison KR, Wuest WM, Brunel JM.

ChemMedChem. 2018 May 23;13(10):1018-1027. doi: 10.1002/cmdc.201800073. Epub 2018 Apr 10.

PMID:
29465814
5.

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.

Brusotti G, Montanari R, Capelli D, Cattaneo G, Laghezza A, Tortorella P, Loiodice F, Peiretti F, Bonardo B, Paiardini A, Calleri E, Pochetti G.

Sci Rep. 2017 Jul 18;7(1):5777. doi: 10.1038/s41598-017-05666-6.

6.

Voltage-Dependent Inhibition of Glycine Receptor Channels by Niflumic Acid.

Maleeva G, Peiretti F, Zhorov BS, Bregestovski P.

Front Mol Neurosci. 2017 May 16;10:125. doi: 10.3389/fnmol.2017.00125. eCollection 2017.

7.

Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features.

Saultier P, Vidal L, Canault M, Bernot D, Falaise C, Pouymayou C, Bordet JC, Saut N, Rostan A, Baccini V, Peiretti F, Favier M, Lucca P, Deleuze JF, Olaso R, Boland A, Morange PE, Gachet C, Malergue F, Fauré S, Eckly A, Trégouët DA, Poggi M, Alessi MC.

Haematologica. 2017 Jun;102(6):1006-1016. doi: 10.3324/haematol.2016.153577. Epub 2017 Mar 2.

8.

Ascorbic acid drives the differentiation of mesoderm-derived embryonic stem cells. Involvement of p38 MAPK/CREB and SVCT2 transporter.

Rahman F, Bordignon B, Culerrier R, Peiretti F, Spicuglia S, Djabali M, Landrier JF, Fontes M.

Mol Nutr Food Res. 2017 May;61(5). doi: 10.1002/mnfr.201600506. Epub 2017 Feb 15.

PMID:
27957816
9.

Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.

Poggi M, Canault M, Favier M, Turro E, Saultier P, Ghalloussi D, Baccini V, Vidal L, Mezzapesa A, Chelghoum N, Mohand-Oumoussa B, Falaise C, Favier R, Ouwehand WH, Fiore M, Peiretti F, Morange PE, Saut N, Bernot D, Greinacher A, BioResource N, Nurden AT, Nurden P, Freson K, Trégouët DA, Raslova H, Alessi MC.

Haematologica. 2017 Feb;102(2):282-294. doi: 10.3324/haematol.2016.147694. Epub 2016 Sep 23.

10.

Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform.

Stalin J, Harhouri K, Hubert L, Garrigue P, Nollet M, Essaadi A, Muller A, Foucault-Bertaud A, Bachelier R, Sabatier F, Pisano P, Peiretti F, Leroyer AS, Guillet B, Bardin N, Dignat-George F, Blot-Chabaud M.

Cardiovasc Res. 2016 Aug 1;111(3):240-51. doi: 10.1093/cvr/cvw096. Epub 2016 May 11.

PMID:
27170199
11.

The first intracellular loop of GLUT4 contains a retention motif.

Talantikite M, Berenguer M, Gonzalez T, Alessi MC, Poggi M, Peiretti F, Govers R.

J Cell Sci. 2016 Jun 1;129(11):2273-84. doi: 10.1242/jcs.183525. Epub 2016 Apr 27.

12.

Erratum to: CMTX1 patients' cells present genomic instability corrected by CamKII inhibitors.

Mones S, Gess B, Bordignon B, Altié A, Young P, Bihel F, Fraterno M, Peiretti F, Fontes M.

Orphanet J Rare Dis. 2016 Jan 25;11:6. doi: 10.1186/s13023-015-0354-2. No abstract available.

13.

The Transcriptional Effects of PCB118 and PCB153 on the Liver, Adipose Tissue, Muscle and Colon of Mice: Highlighting of Glut4 and Lipin1 as Main Target Genes for PCB Induced Metabolic Disorders.

Mesnier A, Champion S, Louis L, Sauzet C, May P, Portugal H, Benbrahim K, Abraldes J, Alessi MC, Amiot-Carlin MJ, Peiretti F, Piccerelle P, Nalbone G, Villard PH.

PLoS One. 2015 Jun 18;10(6):e0128847. doi: 10.1371/journal.pone.0128847. eCollection 2015.

15.

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice.

Poggi M, Morin SO, Bastelica D, Govers R, Canault M, Bernot D, Georgelin O, Verdier M, Burcelin R, Olive D, Alessi MC, Peiretti F, Nunès JA.

Int J Obes (Lond). 2015 Jun;39(6):977-85. doi: 10.1038/ijo.2015.26. Epub 2015 Mar 16.

PMID:
25771927
16.

Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice.

Karkeni E, Marcotorchino J, Tourniaire F, Astier J, Peiretti F, Darmon P, Landrier JF.

Endocrinology. 2015 May;156(5):1782-93. doi: 10.1210/en.2014-1647. Epub 2015 Mar 2.

PMID:
25730105
17.

The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).

Kara I, Poggi M, Bonardo B, Govers R, Landrier JF, Tian S, Leibiger I, Day R, Creemers JW, Peiretti F.

J Biol Chem. 2015 Jan 30;290(5):2812-21. doi: 10.1074/jbc.M114.592543. Epub 2014 Dec 19.

18.

Ascorbic acid is a dose-dependent inhibitor of adipocyte differentiation, probably by reducing cAMP pool.

Rahman F, Al Frouh F, Bordignon B, Fraterno M, Landrier JF, Peiretti F, Fontes M.

Front Cell Dev Biol. 2014 Aug 7;2:29. doi: 10.3389/fcell.2014.00029. eCollection 2014.

19.

Visfatin is involved in TNFα-mediated insulin resistance via an NAD(+)/Sirt1/PTP1B pathway in 3T3-L1 adipocytes.

Gouranton E, Romier B, Marcotorchino J, Tourniaire F, Astier J, Peiretti F, Landrier JF.

Adipocyte. 2014 Jul 1;3(3):180-9. doi: 10.4161/adip.28729. Epub 2014 Apr 4.

20.

CamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene.

Mones S, Bordignon B, Peiretti F, Landrier JF, Gess B, Bourguignon JJ, Bihel F, Fontés M.

Front Neurosci. 2014 Jun 13;8:151. doi: 10.3389/fnins.2014.00151. eCollection 2014.

21.

Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding.

Canault M, Ghalloussi D, Grosdidier C, Guinier M, Perret C, Chelghoum N, Germain M, Raslova H, Peiretti F, Morange PE, Saut N, Pillois X, Nurden AT, Cambien F, Pierres A, van den Berg TK, Kuijpers TW, Alessi MC, Tregouet DA.

J Exp Med. 2014 Jun 30;211(7):1349-62. doi: 10.1084/jem.20130477. Epub 2014 Jun 23.

22.

Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP mice.

Raeven P, Drechsler S, Weixelbaumer KM, Bastelica D, Peiretti F, Klotz A, Jafarmadar M, Redl H, Bahrami S, Alessi MC, Declerck PJ, Osuchowski MF.

J Thromb Haemost. 2014 Jun;12(6):958-69. doi: 10.1111/jth.12565.

23.

ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation.

Lajoie L, Congy-Jolivet N, Bolzec A, Gouilleux-Gruart V, Sicard E, Sung HC, Peiretti F, Moreau T, Vié H, Clémenceau B, Thibault G.

J Immunol. 2014 Jan 15;192(2):741-51. doi: 10.4049/jimmunol.1301024. Epub 2013 Dec 13.

24.

A derivative of ascorbic acid modulates cAMP production.

Bordignon B, Mones S, Rahman F, Chiron J, Peiretti F, Vidal N, Fontes M.

Biochem Biophys Res Commun. 2013 Sep 13;439(1):137-41. doi: 10.1016/j.bbrc.2013.08.004. Epub 2013 Aug 11.

PMID:
23942115
25.

Palmitoylation of TNF alpha is involved in the regulation of TNF receptor 1 signalling.

Poggi M, Kara I, Brunel JM, Landrier JF, Govers R, Bonardo B, Fluhrer R, Haass C, Alessi MC, Peiretti F.

Biochim Biophys Acta. 2013 Mar;1833(3):602-12. doi: 10.1016/j.bbamcr.2012.11.009. Epub 2012 Nov 16.

26.

The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic stem cells.

Hadadeh O, Barruet E, Peiretti F, Verdier M, Bernot D, Hadjal Y, Yazidi CE, Robaglia-Schlupp A, De Paula AM, Nègre D, Iacovino M, Kyba M, Alessi MC, Binétruy B.

PLoS One. 2012;7(11):e49065. doi: 10.1371/journal.pone.0049065. Epub 2012 Nov 8.

27.

A nonradioisotope chemiluminescent assay for evaluation of 2-deoxyglucose uptake in 3T3-L1 adipocytes. Effect of various carbonyls species on insulin action.

Vidal N, Cavaillé JP, Poggi M, Peiretti F, Stocker P.

Biochimie. 2012 Dec;94(12):2569-76. doi: 10.1016/j.biochi.2012.07.006. Epub 2012 Jul 23.

PMID:
22835478
28.

Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase.

Bernot D, Stalin J, Stocker P, Bonardo B, Scroyen I, Alessi MC, Peiretti F.

J Cell Sci. 2011 Apr 15;124(Pt 8):1224-30. doi: 10.1242/jcs.079889. Epub 2011 Mar 15.

29.

p38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells.

Barruet E, Hadadeh O, Peiretti F, Renault VM, Hadjal Y, Bernot D, Tournaire R, Negre D, Juhan-Vague I, Alessi MC, Binétruy B.

Stem Cells Dev. 2011 Jul;20(7):1233-46. doi: 10.1089/scd.2010.0213. Epub 2010 Nov 24.

PMID:
20954847
30.

Down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) expression is necessary for adipocyte differentiation.

Bernot D, Barruet E, Poggi M, Bonardo B, Alessi MC, Peiretti F.

J Biol Chem. 2010 Feb 26;285(9):6508-14. doi: 10.1074/jbc.M109.078444. Epub 2010 Jan 7.

31.

The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes.

Poggi M, Jager J, Paulmyer-Lacroix O, Peiretti F, Gremeaux T, Verdier M, Grino M, Stepanian A, Msika S, Burcelin R, de Prost D, Tanti JF, Alessi MC.

Diabetologia. 2009 Jun;52(6):1152-63. doi: 10.1007/s00125-009-1267-1. Epub 2009 Jan 31.

PMID:
19183933
32.

[The two sides of ADAM17 in inflammation: implications in atherosclerosis and obesity].

Peiretti F, Canault M, Morange P, Alessi MC, Nalbone G.

Med Sci (Paris). 2009 Jan;25(1):45-50. doi: 10.1051/medsci/200925145. Review. French.

33.

DLG1/SAP97 modulates transforming growth factor alpha bioavailability.

Surena AL, de Faria GP, Studler JM, Peiretti F, Pidoux M, Camonis J, Chneiweiss H, Formstecher E, Junier MP.

Biochim Biophys Acta. 2009 Feb;1793(2):264-72. doi: 10.1016/j.bbamcr.2008.09.005. Epub 2008 Sep 27.

34.

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study.

Morange PE, Tregouet DA, Godefroy T, Saut N, Bickel C, Rupprecht HJ, Lackner K, Barbaux S, Poirier O, Peiretti F, Nalbone G, Juhan-Vague I, Blankenberg S, Tiret L.

J Mol Med (Berl). 2008 Oct;86(10):1153-61. doi: 10.1007/s00109-008-0375-6. Epub 2008 Jul 4.

PMID:
18600307
35.

Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha.

Canault M, Peiretti F, Poggi M, Mueller C, Kopp F, Bonardo B, Bastelica D, Nicolay A, Alessi MC, Nalbone G.

J Pathol. 2008 Apr;214(5):574-83. doi: 10.1002/path.2305.

PMID:
18247429
36.

Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

Canault M, Leroyer AS, Peiretti F, Lesèche G, Tedgui A, Bonardo B, Alessi MC, Boulanger CM, Nalbone G.

Am J Pathol. 2007 Nov;171(5):1713-23. Epub 2007 Sep 14.

37.

Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung.

Poggi M, Paulmyer-Lacroix O, Verdier M, Peiretti F, Bastelica D, Boucraut J, Lijnen HR, Juhan-Vague I, Alessi MC.

J Thromb Haemost. 2007 Dec;5(12):2467-75. Epub 2007 Sep 10.

38.

HDLs activate ADAM17-dependent shedding.

Tellier E, Canault M, Poggi M, Bonardo B, Nicolay A, Alessi MC, Nalbone G, Peiretti F.

J Cell Physiol. 2008 Mar;214(3):687-93.

PMID:
17786981
39.

MRI follow-up of TNF-dependent differential progression of atherosclerotic wall-thickening in mouse aortic arch from early to advanced stages.

Kober F, Canault M, Peiretti F, Mueller C, Kopp F, Alessi MC, Cozzone PJ, Nalbone G, Bernard M.

Atherosclerosis. 2007 Dec;195(2):e93-9. Epub 2007 Jul 30.

PMID:
17662986
40.

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet.

Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, Knauf C, Peiretti F, Verdier M, Juhan-Vague I, Tanti JF, Burcelin R, Alessi MC.

Diabetologia. 2007 Jun;50(6):1267-76. Epub 2007 Apr 11.

PMID:
17426960
41.

Polymorphism A36G of the tumor necrosis factor receptor 1 gene is associated with PAI-1 levels in obese women.

Mavri A, Bastelica D, Poggi M, Morange P, Peiretti F, Verdier M, Juhan-Vague I, Alessi MC.

Thromb Haemost. 2007 Jan;97(1):62-6.

PMID:
17200772
42.

The shedding activity of ADAM17 is sequestered in lipid rafts.

Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan-Vague I, Nalbone G, Peiretti F.

Exp Cell Res. 2006 Dec 10;312(20):3969-80. Epub 2006 Sep 5.

PMID:
17010968
43.

FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity.

Canault M, Tellier E, Bonardo B, Mas E, Aumailley M, Juhan-Vague I, Nalbone G, Peiretti F.

J Cell Physiol. 2006 Aug;208(2):363-72.

PMID:
16619241
44.

The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: possible contribution to elevated plasma levels of soluble TNF alpha receptors.

Canault M, Peiretti F, Kopp F, Bonardo B, Bonzi MF, Coudeyre JC, Alessi MC, Juhan-Vague I, Nalbone G.

Atherosclerosis. 2006 Jul;187(1):82-91. Epub 2005 Oct 7.

PMID:
16214147
45.

Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells.

Peiretti F, Canault M, Bernot D, Bonardo B, Deprez-Beauclair P, Juhan-Vague I, Nalbone G.

J Cell Sci. 2005 Mar 1;118(Pt 5):1061-70.

46.

Proinflammatory properties of murine aortic endothelial cells exclusively expressing a non cleavable form of TNFalpha. Effect on tumor necrosis factor alpha receptor type 2.

Canault M, Peiretti F, Mueller C, Deprez P, Bonardo B, Bernot D, Juhan-Vague I, Nalbone G.

Thromb Haemost. 2004 Dec;92(6):1428-37.

PMID:
15583753
47.

Upregulation of TNF-alpha-induced ICAM-1 surface expression by adenylate cyclase-dependent pathway in human endothelial cells.

Bernot D, Peiretti F, Canault M, Juhan-Vague I, Nalbone G.

J Cell Physiol. 2005 Feb;202(2):434-41.

PMID:
15389590
48.
49.

Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases.

Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, Polakiewicz RD, Sonenberg N, Hershey JW.

EMBO J. 2004 Apr 21;23(8):1761-9. Epub 2004 Apr 8.

50.

Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus.

Canault M, Peiretti F, Mueller C, Kopp F, Morange P, Rihs S, Portugal H, Juhan-Vague I, Nalbone G.

Atherosclerosis. 2004 Feb;172(2):211-8.

PMID:
15019530

Supplemental Content

Loading ...
Support Center